California Medical Products, Inc. v. Tecnol Medical Products, Inc.

921 F. Supp. 1219, 1995 U.S. Dist. LEXIS 20780, 1995 WL 848238
CourtDistrict Court, D. Delaware
DecidedDecember 29, 1995
DocketCivil A. 91-620-LON
StatusPublished
Cited by7 cases

This text of 921 F. Supp. 1219 (California Medical Products, Inc. v. Tecnol Medical Products, Inc.) is published on Counsel Stack Legal Research, covering District Court, D. Delaware primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
California Medical Products, Inc. v. Tecnol Medical Products, Inc., 921 F. Supp. 1219, 1995 U.S. Dist. LEXIS 20780, 1995 WL 848238 (D. Del. 1995).

Opinion

LONGOBARDI, Chief Judge.

I. NATURE AND STAGE OF THE PROCEEDINGS

Plaintiff California Medical Products, Inc. (“CalMed”), also known as Laerdal California, commenced this action for patent infringement on November 18, 1991. CalMed alleges that defendant Tecnol Medical Products (“Tecnol”) manufactures and sells a cervical collar, the 911 First Response Col *1224 lar (the “911 collar”), which infringes U.S. Patent Re. 32,219 (the ’219 patent) both literally and under the doctrine of equivalents. Through its answer and counterclaim for declaratory relief, Tecnol denies that it infringes the ’219 patent and alleges as affirmative defenses that the ’219 patent is invalid and unenforceable on various grounds.

Tecnol has also counterclaimed alleging that CalMed violated 35 U.S.C. § 292 by falsely marking its own cervical collars as patented using the label “Patent No. RE 32,219” between November 8, 1987 and February 22, 1991 while the patent had lapsed. CalMed denies Tecnol’s false marking allegations. Tecnol also seeks a declaratory judgment that a new version of the 911 collar (the “modified 911 collar”) does not infringe the ’219 patent either literally or under the doctrine of equivalents. CalMed contends that the modified 911 collar infringes the ’219 patent under the doctrine of equivalents.

On November 8, 1983, U.S. Patent No. 4,413,619 (the ’619 patent), entitled “Portable Cervical Collar” was issued to Geoffrey C. Garth. The application for the ’619 patent was filed on October 16,1981. On February 10, 1984, Garth filed an application for reissue of the ’619 patent. On August 5, 1986, the ’219 reissue patent, also entitled “Portable Cervical Collar,” was issued to Garth based upon the reissue application. Garth was the sole inventor of and applicant for the ’619 and ’219 patents. The ’219 patent lapsed in November, 1987 following Garth’s failure to pay the required maintenance fee. On or about May 17,1989, Garth executed an assignment of the ’219 patent to CalMed. Following Garth’s petition for reinstatement, the Patent and Trademark Office (“PTO”) reinstated the patent on February 22, 1991.

Following oral argument on motions for summary judgment, the Court found that pursuant to 35 U.S.C. § 41(c)(2) CalMed was precluded as a matter of law from recovering any damages for any infringement by Tecnol occurring during the time period that the ’219 patent had lapsed. In addition to these . mandatory statutory intervening rights, Tecnol contends that it is entitled to equitable intervening rights allowing it to continue to make, use, or sell the 911 collar even after the reinstatement of the ’219 patent. CalMed disputes that such equitable relief is appropriate.

A nine day non-jury trial yielded a transcript of 2,223 pages. In addition, the parties designated over 1,660 pages of deposition testimony and approximately 300 exhibits were received into evidence. The parties have submitted post-trial briefing and proposed findings of fact and conclusions of law. 1

This Court has jurisdiction over the subject matter of the claims and counterclaims of this action pursuant to 28 U.S.C. § 1331, § 1338(a), § 2201, and § 2202.

This Memorandum Opinion represents the Court’s findings of fact and conclusions of law with respect to all issues.

II. TECHNOLOGICAL BACKGROUND

The technology at issue in this case involves cervical collars which are utilized to restrict the motion of a patient’s head and neck. Cervical collars are utilized both before (“pre-hospitalization” or “extrication” collars) and after (“post-hospitalization” collars) a patient is hospitalized. At an accident scene it is not possible for emergency per *1225 sonnel to fully evaluate the condition of a patient’s neck and spine. It is necessary, therefore, to immobilize the patient’s neck to prevent further injury. Extrication collars are used by paramedics to minimize the motion of a patient’s neck while administering initial treatment, extricating the patient from, for example, automobile wreckage, and transporting the patient to the hospital.

The 911 collar, the modified 911 collar, the Stifneck collar (the extrication collar marketed by CalMed), and the collar claimed in the ’219 patent all accomplish significant immobilization of the patient’s neck. Without preempting or prejudicing the Court’s claim construction and infringement analysis, neither side could disagree that there are some obvious similarities between these collars. All obtain the desired immobilization by utilizing a structure which encircles the patients neck and an attached structure which supports the patients chin. These structures are comprised of material which can be described as stiff yet flexible. 2 The Court will refer in this Memorandum Opinion to the portion of a cervical collar which encircles the patient’s neck as the “band,” and the portion of the collar which supports the patients chin as the “chin support brace.”

Post-hospitalization collars differ from extrication collars in that they are often constructed out of softer materials, such as foam rubber and thus do not provide the same degree of immobilization as extrication collars. While the distinction between extrication collars and post-hospitalization collars is useful in obtaining an understanding of the cervical collar industry it is not a distinction that is of significance in resolving infringement and validity issues, because the claims of the ’219 patent do not explicitly distinguish between these two categories of cervical collars. The accused collars do not infringe simply because they can be characterized as extrication collars, and relevant prior art does not become irrelevant simply because it can be characterized as a post-hospitalization collar.

The 911 collar, [Plaintiffs Trial Exhibit (“PX”) 3] is comprised of three main structural pieces: two band sections, which the Court will refer to as the front band section and the back band section, and a chin support brace. The front band section is comprised of three layers of material. The top layer is a gray, stiff flexible material. The middle layer is a thin layer of plastic which is a lighter shade of grey. The middle layer is the same shape and size as the top layer. The bottom layer is a soft white foam which extends beyond the bottom edge of the first two layers, thus providing additional padding for the comfort of the patient. The front band section has a hole in the middle, referred to as a “trach hole,” which allows medical personnel to perform a surgical procedure to provide an airway through the trachea while the patient is wearing the collar.

The back band section and the chin support brace lack the middle plastic layer found in the front band section. The grey material and the white foam are the same shape and size in the chin support brace.

Free access — add to your briefcase to read the full text and ask questions with AI

Related

Burandt v. Dudas
496 F. Supp. 2d 643 (E.D. Virginia, 2007)
Clontech Laboratories, Inc. v. Invitrogen Corp.
263 F. Supp. 2d 780 (D. Delaware, 2003)
Gentile v. Franklin Sports, Inc.
211 F. Supp. 2d 334 (D. Massachusetts, 2002)
R.R. Donnelley & Sons Co. v. Dickinson
123 F. Supp. 2d 456 (N.D. Illinois, 2000)
Allied Tube and Conduit Corp. v. John Maneely Co.
125 F. Supp. 2d 987 (D. Arizona, 2000)
Wooster Brush Co. v. Newell Operating Co.
46 F. Supp. 2d 713 (N.D. Ohio, 1999)

Cite This Page — Counsel Stack

Bluebook (online)
921 F. Supp. 1219, 1995 U.S. Dist. LEXIS 20780, 1995 WL 848238, Counsel Stack Legal Research, https://law.counselstack.com/opinion/california-medical-products-inc-v-tecnol-medical-products-inc-ded-1995.